Market

Global Automation in Biopharma Market to Surge by 2031: Key Trends and Forecasts
Management & Regulatory Global Automation in Biopharma Market to Surge by 2031: Key Trends and Forecasts

Global Automation in Biopharma Market to Surge by 2031: Key Trends and Forecasts The global biopharma market is on the cusp of remarkable transformations driven by automation, enabling more efficient production processes and improved product quality. This evolving sector is undergoing significant

Is AbbVie Poised for Growth with Its 2022 Financial Strategy and Acquisitions?
Management & Regulatory Is AbbVie Poised for Growth with Its 2022 Financial Strategy and Acquisitions?

AbbVie's financial performance and strategic initiatives in 2022 demonstrate a concerted effort to drive growth and enhance its presence in the pharmaceutical and biopharmaceutical sectors. With revenues exceeding $58 billion, the year reflected significant advancements fueled by new product

Will J&J or Novartis Acquire Legend Biotech Amid Market Speculation?
Management & Regulatory Will J&J or Novartis Acquire Legend Biotech Amid Market Speculation?

The biopharma industry is abuzz with rumors of a potential takeover of CAR-T specialist Legend Biotech, a company renowned for its collaboration with Johnson & Johnson (J&J) on the BCMA CAR-T therapy Carvykti. An unnamed source cited by StreetInsider has revealed that Legend recently

Is Arbutus Biopharma's Recent Market Surge a Sign of Future Growth?
Management & Regulatory Is Arbutus Biopharma's Recent Market Surge a Sign of Future Growth?

Arbutus Biopharma Corporation (NASDAQ:ABUS) has recently garnered considerable attention in the financial markets, experiencing a significant surge in its stock value. The company's stock recently hit a new 52-week high of $3.65 during mid-day trading on a Friday, ultimately closing at $3.60

How Is Esteve's Expansion Shaping the Global Pharmaceutical Industry?
Management & Regulatory How Is Esteve's Expansion Shaping the Global Pharmaceutical Industry?

The global pharmaceutical industry is undergoing a transformative phase, driven by rapid advancements in technology, increasing demand for healthcare solutions, and strategic expansions by leading companies. Esteve Pharmaceuticals, a major player in the sector, is making headlines with its

Sutro Biopharma Inc Faces Significant Stock Volatility and Revenue Decline
Management & Regulatory Sutro Biopharma Inc Faces Significant Stock Volatility and Revenue Decline

Sutro Biopharma Inc. (NASDAQ:STRO) has been experiencing a challenging period, marked by considerable stock price fluctuations and substantial revenue declines. This California-based biotech firm, specializing in oncology therapeutics, is grappling with mixed sentiments among investors amidst a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later